CLOSE
Enter Website

Our site stores cookies on your computer. These cookies are used to offer more personalised services and improve each day. Continuing to browse our site implies acceptance of our cookie policy. See our legal notes or Close

_01

Expertise Line

API

In our production sites we mill a broad range of drug substances in multipurpose equipment with proven experience.

HPAPI

We are equipped with containment solutions (Glove- and Half Suit Boxes) to mill highly potent ingredients.

STEROID

This product category can be processed thanks to dedicated micronization lines.

FOOD & EXCIPIENT

In our production sites, excipients are milled in GMP equipment. The food ingredients are processed in dedicated lines with the same standard we are used to apply to pharmaceuticals.

NEW FRONTIERS

For more than 40 years, never ceasing to invest in research and in new contents on Micronization, in a much wider and integrated approach, has always been the sense of our job. Understanding and discerning evolving needs is a foremost task for a company providing services like ours.

_02

Service Line

PROCESS DEVELOPMENT

we offer our expertise to develop robust processes through DoE studies.

JET-, PIN- AND HAMMER MILLING

We provide to our customers micronization and milling services with a deep experience in the particle size reduction.

CO-MICRONIZATION

The simultaneous micronization of at least two compounds improves powder properties and skip potential blending steps.

MICRONIZATION UNDER CONTAINMENT

We are equipped with containment isolators, as part of a systematic approach to control the safe handling for potent compound.

POST MILLING CONDITIONING

With product conditioning we are able to resolve post micronization morphological issues.

QUALITY BY DESIGN

Before the Process Validation activity, we support our customers with an approach to QbD by the identification of the Critical Process Parameters (CPP), to be studied during the following Design of Experiment (DoE) development step.

CRYOGENIC MICRONIZATION

We provide to our customers particle size reduction by jet milling to very low temperature, for those compounds with a low brittleness and tacky, elastic polymers or semi-solid in nature. It is also used to prevent the degradation of highly sensitive products, to avoid polymorphic changes and to avoid any increase in amorphous particles.

ANALYTICAL SERVICES

We provide services for PSD analysis and related activities as method development, method validation, method transfer, etc. with our cutting-edge equipment.

NEW CLIENT’S NEEDS

Over time, our customers have requested newer and newer services depending on the market complexity. We have always worked embracing a concept of recognition and acceptance of Problem Solving, in a broad and factual sense. We have often been innovators in found and implemented solutions.

_03

Strategy Line

CONFIDENTIALITY

We guarantee a full confidentiality to our customers which rely on us as part of the development of new compounds.

INDEPENDENCE

The company, firmly in the hands of the founder’s second generation, continues along the path of complete independence able to ensure flexibility and avoid any conflict of interest towards its clients.

BUSINESS CONTINUITY PLAN

We ensure our customers having created a system of prevention and recovery from potential threats to the company.

ADVISORY SUPPORT

We accompany our clients with expertise, supporting them with regular consulting services for each step of the projects.

PARTNERSHIP

We consider our expertise and experience as basic concept for a long-lasting partnership with our customers.

INDEPENDENCE CONSOLIDATION

The milestones of our company philosophy are firmly pursued by the second generation and among them the guarantee of stability and business continuity. Elements that ensure flexibility, the respect of privacy and confidentiality of our whole profession.

_04

Key Factor

Proprietary Technology

We constantly improve the technology of our in-house designed mills which generates a precise scalability and maximizes the micronization yields

LEAD TIME

We provide a smart management of the projects evaluating the overall duration of the critical path in order to save time by accomplish customer´s needs.

FLEXIBILITY

We accommodate the needs of our customers adapting the day-to-day shifts with the willingness and ability to readily respond to changing circumstances and expectations.

R&D

We support our customers in their R&D process with our knowledge in particle size engeeneering

DOUBLING PRODUCTION CAPACITY

We have arranged a significant investment plan in our production sites that will entrain the doubling of our production and Micronization capacity. This decision was made to guarantee better and more performing lead times toward a market demanding such an expertise.

News

27 February 2020
Formulation & Drug Delivery Series US in San Diego

Welcoming over 250 key leaders, the Formulation & Drug Delivery Congress will discuss the state of the industry, looking at new strategies for optimizing biologic formulations such as antibodies, proteins and vaccines, as well as highlighting key updates in amorphous solid dispersions and combination products. Munit will participate the Formulation and Drug Delivery Summit in …

11th Global Drug Delivery & Formulation Summit in Berlin

We announce our participation at the 11th Global Drug Delivery & Formulation Summit (March 9th – 11th 2020) in Berlin. MUnit, your partner for the micronisation of API’s and High Potent Materials, will be pleased to welcome you at our booth. For more information, visit: www.ddfevent.com

10th World ADC in London

Now in its 10th year, World ADC London prides itself in being the industry-leading conference to help forward thinking researchers from the pharmaceutical, biotech and academic community advance the development of antibody-drug conjugates. Get together with 320 experts across 140+ active organisations as they unite at this industry focussed conference and foster new connections, develop …

CPHI JAPAN 2020 HAS BEEN POSTPONED

The event, which was due to take place from 16th – 18th March 2020, has been put on hold. The decision to postpone the event was not one taken lightly and has been taken in agreement with all stakeholders involved. We are currently looking into alternative dates and venues for CPhI Japan 2020 and will …

Jetpharma

 

Mr. Maurizio Schiavazzi

Chief Commercial Officer

mschiavazzi(a)munit.com

Jetpharma

 

Mr. Giovanni Frigerio

Chief Scientific Officer

gfrigerio(a)munit.com

Jetpharma

 

Ms. Katia Zocca

Customer Care

kzocca(a)munit.com

Jetpharma

 

Mr. Uwe Heidenreich

Business Development Manager

uheidenreich(a)munit.com

Jetpharma

 

Mr. Massimo Dal Bosco

Business Development Manager

mdalbosco(a)munit.com

Jetpharma

MUNIT SA
Via Crocicchio Cortogna 6
CH-6900 Lugano

Jetpharma

T. +41 (0)91 910 30 80

Jetpharma

contact(at)munit.com